SCHEMBL3903706

SCHEMBL3903706

CCc1ccc2c(c1N)C(=O)c1cscc1-2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.37
▸ MAPK1 P28482 3/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ HBB P68871 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ MEN1 O00255 3/20 0.33
▸ POLB P06746 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ THRB P10828 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3899297 0.79 ALDH1A1 (0.59) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL6682201 0.76 MAPK1 (0.64) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL3904655 0.76 ALDH1A1 (0.40) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL3904075 0.76 ALDH1A1 (0.40) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL3904558 0.75 RAB9A (0.44) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL3897401 0.72 ALDH1A1 (0.40) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL3902083 0.70 PABPC1 (0.33) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL3898403 0.69 MEN1 (0.69) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL3900138 0.69 MAPT (0.41) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL3902705 0.68 ADORA2A (0.60) ALDH1A1MAPK1L3MBTL1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383463-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS INC (US) 2009-03-25 — — EP claimed
EP-1383463-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE King Pharmaceuticals, Inc. (US) 2004-01-28 — — EP claimed
WO-2002083083-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS, INC. (US) 2002-10-24 — — WO claimed
EP-1383463-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS INC (US) 2009-03-25 — — EP disclosed
EP-1383463-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE King Pharmaceuticals, Inc. (US) 2004-01-28 — — EP disclosed
WO-2002083083-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS, INC. (US) 2002-10-24 — — WO disclosed
Send feedback